New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.
about
Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe.Positive association between leptin serum levels and disease activity on endoscopy in inflammatory bowel disease: A case-control study.Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis.
P2860
New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
New Biomarkers for Diagnosing ...... Assessing Treatment Outcomes.
@en
type
label
New Biomarkers for Diagnosing ...... Assessing Treatment Outcomes.
@en
prefLabel
New Biomarkers for Diagnosing ...... Assessing Treatment Outcomes.
@en
P2860
P1476
New Biomarkers for Diagnosing ...... Assessing Treatment Outcomes.
@en
P2093
Robert Burakoff
P2860
P304
P356
10.1097/MIB.0000000000000903
P577
2016-12-01T00:00:00Z